A Comparative study on the effectiveness of wiesbaden and individualised homoeopathic treatment in hairfall

To Evaluate the efficacy of Wiesbaden vs Individualised Homoeopathic Medicine in the management of Telogen effluvium - A Prospective open labelled double arm Randomised control study - NIL

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/109446

Enrollment

Registered

2026-04-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L650- Telogen effluvium

Interventions

Intervention1: Wiesbaden potency: Wiesbaden in appropriate potency will be given to patients diagnosed with Telogen effluvium The medicine will be given in fixed potency and dosage at regular interva

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS WITH HYPOTHYROIDISM AND HYPERTHYROIDISM PATIENTS WITH NUTRITIONAL DISORDERS PATIENTS WITH STRESS EVENTS(LIKE FEBRILE ILLNESS,PSYCHOLOGICALSTRESS,PHYSICAL STRESS) POST PARTUM FEMALES

Exclusion criteria

Exclusion criteria: PATIENTS TAKING OTHER MODES OF TREATMENT SUBJECTS WITH AGE BELOW 18 AND ABOVE 48 PATIENTS WITH TERMINAL ILLNESS PATIENTS WITH ANDROGENIC ALOPECIA, ALOPECIA AREATA PATIENTS UNDER RADIO AND CHEMOTHERAPY

Design outcomes

Primary

Measure	Time frame
TO EVALUATE THE ROLE OF WIESBADEN AND INDIVIDUAL HOMOEOPATHIC MEDICINES IN THE MANAGEMENT OF TELOGEN EFFLUVIUMTimepoint: 24 MONTHS	—

Secondary

Measure	Time frame
TO EVALUATE THE ROLE OF INDIVIDUALISED HOMOEOPATHIC MEDICINE IN THE MANAGEMENT OF TELOGEN EFFLUVIUMTimepoint: 24 MONTHS	—

Countries

India

Contacts

Public ContactDR J VINOD KUMAR

J.S.P.S Government Homoeopathic Medical College

gundlapravalikareddy@gmail.com9640164409

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 11, 2026